Unveiling a novel AAK1 inhibitor: How chemical proteomics unlocked therapeutic potential
Researchers find novel inhibitors targeting the AAK1 catalytic domain, paving the way for more efficient drug discovery in life-threatening diseases.
2024-05-24
(Press-News.org)
Enhancing drug development for life-threatening diseases like cancer hinges on a deep understanding of protein kinases, making it a focal point for researchers. These enzymes, encoded by more than 500 human genes, serve as critical players in cellular signaling pathways. However, if these signals are dysregulated, they can disrupt the normal cellular mechanisms, leading to diseases such as cancer. Protein kinase inhibitors have therefore provided a promising avenue in therapeutic intervention to disrupt the aberrant signaling mechanisms underlying such diseases.
Due to the similarity and complexity of kinase structures, the development of effective kinase inhibitors has so far presented a formidable challenge for the researchers. Finding specific inhibitors among various potential targets has been a hurdle, until now. A team led by Professor Hiroshi Tokumitsu from the Graduate School of Interdisciplinary Science and Engineering in Health Systems at Okayama University, along with a graduate student Ms. Akari Yoshida and Dr. Satomi Ohtsuka from Okayama University with Professor Ulf J. Nilsson from Lund University and Professor Teruhiko Ishikawa from the Graduate School of Education at Okayama University, published a study in Scientific Reports on 20 March 2024. The study sheds light on a novel inhibitor targeting Adaptor Protein 2-Associated Protein Kinase 1 (AAK1).
Talking about the inspiration, Prof. Tokumitsu states, “Through years of dedicated research into intracellular signaling mechanisms, we've crafted protein kinase inhibitors as potent analytical instruments for fundamental life sciences." And now it was time to see their achievements in action.
Their study introduced an innovative method utilizing Kinobeads technology. This cutting-edge approach enabled the team to explore the interactions between TIM-063, originally formulated as a Ca2+/calmodulin-dependent protein kinase kinase (CaMKK) inhibitor, and numerous protein kinases, with a particular focus on AAK1. Through immobilization onto sepharose beads, TIM-063-sepharose complexes were created to capture target kinases from cellular extracts selectively. After extensive washing to remove nonspecific proteins, bound kinases were eluted and identified through mass spectrometry. This meticulous approach shed light on TIM-063's binding to AAK1's catalytic domain, offering insights into its inhibitory mechanism. By elucidating the binding of TIM-063 to AAK1's catalytic domain, the researchers established a foundation for targeted inhibition.
“Our research highlights the potential of repurposing existing kinase inhibitors as lead compounds for novel therapeutic targets”, states Prof. Tokumitsu. “By leveraging kinase inhibitor development methods, starting with identifying enzymes that interact with existing inhibitors, promises a rapid drug discovery cycle with protein kinases as the molecular target," He further adds.
The study's focus on AAK1, associated with various neurological disorders and viral infections, highlights the promise of targeted inhibitors. These findings open doors for innovative drug development, particularly in addressing unmet medical needs in conditions such as schizophrenia, Parkinson's disease, and viral infections. "In the era of costly and time-consuming drug discovery, our research stands to significantly contribute by facilitating the development of rapid and cost-effective enzyme inhibitors with clinical applications,” states Prof. Tokumitsu.
This breakthrough has the potential to revolutionize drug discovery, offering a more streamlined approach to developing enzyme inhibitors with real clinical applications. With this advancement, researchers aim to address critical healthcare challenges and improve patient well-being.
About Okayama University, Japan
As one of the leading universities in Japan, Okayama University aims to create and establish a new paradigm for the sustainable development of the world. Okayama University offers a wide range of academic fields, which become the basis of the integrated graduate schools. This not only allows us to conduct the most advanced and up-to-date research but also provides an enriching educational experience.
Website: https://www.okayama-u.ac.jp/index_e.html
About Professor Hiroshi Tokumitsu from Okayama University, Japan
Hiroshi Tokumitsu is a highly accomplished Professor at the School of Engineering and Graduate School of Interdisciplinary Science and Engineering in Health Systems. With an impressive h-index of 41 and over 6,230 citations, he has made significant contributions to the fields of calcium-calmodulin-dependent protein kinases and phosphotransferases. Prof. Tokumitsu's research focuses on understanding the molecular mechanisms underlying cellular signaling pathways, particularly in relation to calcium signaling and protein phosphorylation. His extensive publication record of 124 research outputs demonstrates his expertise and dedication to advancing biomedical science.
END
ELSE PRESS RELEASES FROM THIS DATE:
2024-05-24
In recent years, global environmental concerns have prompted a shift toward eco-friendly manufacturing in the field of organic synthetic chemistry. In this regard, research into photoredox catalytic reactions, which use light to initiate redox or reduction-oxidation reactions via a photoredox catalyst, has gained significant attention. This approach reduces the reliance on harsh and toxic reagents and uses visible light, a clean energy source.
A key research area has been the development of recycling methods for photocatalysts, which offer both economic and environmental benefits. Photocatalysts use light to accelerate a chemical reaction without getting consumed in the process, and photoredox ...
2024-05-24
Researchers have developed a method to make adaptive and eco-friendly sensors that can be directly and imperceptibly printed onto a wide range of biological surfaces, whether that’s a finger or a flower petal.
The method, developed by researchers from the University of Cambridge, takes its inspiration from spider silk, which can conform and stick to a range of surfaces. These ‘spider silks’ also incorporate bioelectronics, so that different sensing capabilities can be added to the ‘web’.
The fibres, at least 50 times smaller than a ...
2024-05-24
Splash a few drops of water on a hot pan and if the pan is hot enough, the water will sizzle and the droplets of water seem to roll and float, hovering above the surface.
The temperature at which this phenomenon, called the Leidenfrost effect, occurs is predictable, usually happening above 230 degrees Celsius. The team of Jiangtao Cheng, associate professor in the Virginia Tech Department of Mechanical Engineering, has discovered a method to create the aquatic levitation at a much lower temperature, and the results have been published in Nature ...
2024-05-24
Researchers at Rensselaer Polytechnic Institute have fabricated a device no wider than a human hair that will help physicists investigate the fundamental nature of matter and light. Their findings, published in the journal Nature Nanotechnology, could also support the development of more efficient lasers, which are used in fields ranging from medicine to manufacturing.
The device is made of a special kind of material called a photonic topological insulator. A photonic topological insulator can guide photons, the wave-like particles that make up light, ...
2024-05-24
The study, a collaboration between researchers at Imperial College London and GNS Science, suggests that reducing plastic pollution by 5% per year would stabilize the level of microplastics – plastics less than 5 mm in length – in the surface oceans.
However, the modelling shows that even reducing pollution by 20% per year would not significantly reduce existing microplastics levels, meaning they will persist in our oceans beyond 2100.
Microplastics have been found to be circulating in all of the Earth’s oceans and some of the greatest concentrations of them are thousands of miles from land. These tiny particles ...
2024-05-24
The DRIVE-RM consortium, led by Professor of Experimental Nephrology Marianne Verhaar from UMC Utrecht, has been awarded €37.5 million under the prestigious NWO SUMMIT program. The SUMMIT grant recognizes world-class collaborations, while further strengthening these partnerships. The DRIVE-RM collaboration involves UMC Utrecht, Utrecht University, Eindhoven University of Technology, Maastricht University, and the Hubrecht Institute, focusing on smart materials that assist the body in healing.
Regenerative medicine involves repairing or replacing damaged tissues and organs by leveraging the body's own healing processes. DRIVE-RM ...
2024-05-24
MIAMI, FLORIDA (MAY 23, 2024) – The treatment landscape for multiple myeloma, the second most common blood cancer, is shifting rapidly, with newly diagnosed patients increasingly being treated with a four-part drug combination that includes a new immunotherapy agent.
Over the last decade, options have evolved from double, to triple to quadruple combination therapies. What do these new options mean for patients, and how will treatment change in the future?
C. Ola Landgren, M.D., Ph.D., will ...
2024-05-24
JST has selected winners for the third Marie Sklodowska Curie Award for young female researchers. For the third Marie Sklodowska Curie Award, we accepted applications from October 2 to December 11, 2023. Through document screenings and interviews with external experts, we have selected one Grand Prize winner and two Inspiration Prize winners. JEOL Ltd. will award 1M yen for the Grand Prize and 500K yen for each Inspiration Prize.
JST recognizes the importance of initiatives designed to promote the activities of female researchers in science, technology, and innovation, and based on this belief we established the “Marie ...
2024-05-24
Life-changing events like the birth of a child, the purchase of a new home, or a lottery win could threaten the survival of a new business venture, research from Edith Cowan University (ECU) has found.
A recent study led by ECU’s Professor of Entrepreneurship and Innovation Pi-Shen Seet with Associate Professor Wee-Liang Tan from the Singapore Management University found that positive family events had a comparatively greater influence, albeit negatively, on the survival of a new venture, compared with negative events.
“A positive family event, like the birth of a child, often has an emotional spin-on effect for an entrepreneur ...
2024-05-24
Robert Wagner, associate laboratory director for the Energy Science and Technology Directorate at the Department of Energy’s Oak Ridge National Laboratory, has been selected to receive the George Westinghouse Gold Medal from the American Society of Mechanical Engineers, or ASME. The award recognizes his work to advance state-of-the-art clean power generation systems through research on combustion, fuel technologies and controls.
Wagner will be presented the award in October during ASME’s ...
LAST 30 PRESS RELEASES:
[Press-News.org] Unveiling a novel AAK1 inhibitor: How chemical proteomics unlocked therapeutic potential
Researchers find novel inhibitors targeting the AAK1 catalytic domain, paving the way for more efficient drug discovery in life-threatening diseases.
